c omparative e valuation of i ntralesional t riamcinolone a cetonide i njection, n arrow b and u...
If you can't read please download the document
DESCRIPTION
AIMS AND OBJECTIVES : 1. To evaluate the therapeutic efficacy of intralesional triamcinolone acetonide injection 2.5 mg/ml in AA. 2. To assess the therapeutic efficacy of NBUVB in AA. 3. To assess the therapeutic efficacy of combined intralesional triamcinolone acetonide injection 2.5 mg/ml & NBUVB in AA. 4. Comparative evaluation of intralesional triamcinolone acetonide injection 2.5 mg/ml, NBUVB, & their combination in AA.TRANSCRIPT
C OMPARATIVE E VALUATION OF I NTRALESIONAL T RIAMCINOLONE A CETONIDE I NJECTION, N ARROW B AND U LTRAVIOLET B, AND THEIR C OMBINATION IN A LOPECIA A REATA Sandeep Kaur et al International journal of trichology Oct-Dec 2015 Alopecia areata recurrent, chronic, autoimmune, nonscarring type of hair loss that can affect any hair bearing area occurring in genetically predisposed individuals. Intralesional CS -- extensively used Mx of AA. First line Rx --localized alopecia involving